Τίτλος:
Ixazomib Plus Lenalidomide-Dexamethasone (IRd) in Relapsed/Refractory
Multiple Myeloma (MM) Patients (Pts) - Effectiveness in Routine Clinical
Practice Is Similar to the Efficacy in the Phase 3 Tourmaline-MM1 Trial:
A Pooled Analysis from the Insight MM Observational Study and the Czech
Registry of Monoclonal Gammopathies (RMG)
Συγγραφείς:
Hajek, Roman
Terpos, Evangelos
Lee, Hans C.
Chari, Ajai and
Costello, Caitlin L.
Puig, Noemi
Leleu, Xavier
Berdeja,
Jesus G.
Davies, Faith E.
Weisel, Katja
Usmani, Saad Z. and
Hungria, Vania T. M.
Boccadoro, Mario
Rifkin, Robert M. and
Zonder, Jeffrey A.
Cook, Gordon
Brozova, Lucie
Barinova,
Magda
Ren, Kaili
Cacioppo, Roxanne
Skacel, Tomas
Stull,
Dawn Marie
Maisnar, Vladimir
